3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
8
Colonic Neoplasms
7
Neoplasms
5
Colorectal Neoplasms
5
Multiple Myeloma
4
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
Adenomatous Polyposis Coli
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
328
Methotrexate
182
Cytarabine
164
fludarabine phosphate
151
Vincristine
128
Dexamethasone
126
fludarabine
123
Peripheral Blood Stem Cell Transplantation
116
Whole-Body Irradiation
108
Etoposide
106
Mycophenolic Acid
105
Tacrolimus
95
Busulfan
95
Filgrastim
93
Melphalan
81
Cyclosporine
80
Rituximab
79
Doxorubicin
79
Mercaptopurine
70
Radiotherapy
62
Antilymphocyte Serum
62
Prednisone
57
Granulocyte Colony-Stimulating Factor
57
blinatumomab
55
pegaspargase
54
Asparaginase
54
Thiotepa
52
Daunorubicin
52
Calcium Dobesilate
47
Clofarabine
45
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Curcumin
×
Clear all
NCT05045443
2024-01-08
CurcumPedALL
Ain Shams University
Phase 2
Completed
30 enrolled